Chief financial officers are dealing with a relatively new problem: having too much data available at their fingertips, according to a survey from Ernst & Young.

Brightness of the shoulder’s deltoid muscle on ultrasound can identify patients with type 2 diabetes or pre-diabetes with almost 90 percent accuracy, according to a study being presented at the Radiological Society of North America (RSNA)’s 2018 Annual Meeting next week in Chicago.

Several wildfires in California led HHS Secretary Alex Azar to declare a public health emergency in the state on Nov. 13. The announcement allows CMS providers, suppliers and beneficiaries flexibility to meet emergency needs.

A deep-learning system (DLS) designed by Google researchers outperformed several top general pathologists when grading prostate cancer on a standard grade, according to newly-published research.  

LifePoint Health, a healthcare services company based in Tennessee, and RCCH HealthCare Partners completed their $5.6 billion merger on Nov. 16. The deal was originally announced in July.

Playing a single season of high school football can cause changes in the structure of an athlete’s brain, according to new research published in Neurobiology of Disease.

Children undergoing chest CT are probably better off with no lead apron shielding the abdomen and pelvis.

As 3D printing continues to gain traction as a medical treatment tool, cardiologists across the globe are implementing the technology in their own departments and practices. But as they do, one radiologist cautions, it’s important they consider some critical groundwork that’s yet to be laid.

“The new 2018 Digital Mammography QC Manual will promote uniformity and consistency of QC procedures across the broad spectrum of FDA approved manufacturers,” Eric Berns, PhD, manual author and chair of the ACR Subcommittee on Mammography Quality Assurance, said in a prepared statement.

A New York City-based medtech startup called Ezra is about to replace pain inducing blood tests and biopsies with MRIs as part of its new prostate cancer screening subscription service, according to a recent report by TechCrunch.